Juno, Millennium settle patent dispute over cancer drug Velcade

Intellectual Property 2019-09-30 11:56 am | Sydney
Generic drug maker Juno Pharmaceuticals and US-based Millennium Pharmaceuticals have reached an in-principle settlement in their trans-Pacific dispute over two patents covering breakthrough anti-cancer medication Velcade.
For information on rights and reprints, contact subscriptions@lawyerly.com.au